123 related articles for article (PubMed ID: 15845619)
1. Central relaxin-3 administration causes hyperphagia in male Wistar rats.
McGowan BM; Stanley SA; Smith KL; White NE; Connolly MM; Thompson EL; Gardiner JV; Murphy KG; Ghatei MA; Bloom SR
Endocrinology; 2005 Aug; 146(8):3295-300. PubMed ID: 15845619
[TBL] [Abstract][Full Text] [Related]
2. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
3. Central and peripheral administration of human relaxin-2 to adult male rats inhibits food intake.
McGowan BM; Minnion JS; Murphy KG; White NE; Roy D; Stanley SA; Dhillo WS; Gardiner JV; Ghatei MA; Bloom SR
Diabetes Obes Metab; 2010 Dec; 12(12):1090-6. PubMed ID: 20977581
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
Schwartz MW; Sipols AJ; Marks JL; Sanacora G; White JD; Scheurink A; Kahn SE; Baskin DG; Woods SC; Figlewicz DP
Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
[TBL] [Abstract][Full Text] [Related]
5. Relaxin-3 stimulates the neuro-endocrine stress axis via corticotrophin-releasing hormone.
McGowan BM; Minnion JS; Murphy KG; Roy D; Stanley SA; Dhillo WS; Gardiner JV; Ghatei MA; Bloom SR
J Endocrinol; 2014 May; 221(2):337-46. PubMed ID: 24578294
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of central administration of relaxin-3 on food intake and hypothalamic neuropeptides in male and female rats.
Calvez J; Lenglos C; de Ávila C; Guèvremont G; Timofeeva E
Genes Brain Behav; 2015 Sep; 14(7):550-63. PubMed ID: 26234422
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats.
McGowan BM; Stanley SA; White NE; Spangeus A; Patterson M; Thompson EL; Smith KL; Donovan J; Gardiner JV; Ghatei MA; Bloom SR
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E913-9. PubMed ID: 17132825
[TBL] [Abstract][Full Text] [Related]
8. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135.
Liu C; Eriste E; Sutton S; Chen J; Roland B; Kuei C; Farmer N; Jörnvall H; Sillard R; Lovenberg TW
J Biol Chem; 2003 Dec; 278(50):50754-64. PubMed ID: 14522968
[TBL] [Abstract][Full Text] [Related]
9. Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat.
Vrang N; Larsen PJ; Kristensen P; Tang-Christensen M
Endocrinology; 2000 Feb; 141(2):794-801. PubMed ID: 10650962
[TBL] [Abstract][Full Text] [Related]
10. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
Sutton SW; Bonaventure P; Kuei C; Nepomuceno D; Wu J; Zhu J; Lovenberg TW; Liu C
Neuroendocrinology; 2005; 82(3-4):139-50. PubMed ID: 16679775
[TBL] [Abstract][Full Text] [Related]
11. Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing.
Sutton SW; Bonaventure P; Kuei C; Roland B; Chen J; Nepomuceno D; Lovenberg TW; Liu C
Neuroendocrinology; 2004; 80(5):298-307. PubMed ID: 15677880
[TBL] [Abstract][Full Text] [Related]
12. Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction.
Xu B; Kalra PS; Farmerie WG; Kalra SP
Endocrinology; 1999 Jun; 140(6):2868-75. PubMed ID: 10342879
[TBL] [Abstract][Full Text] [Related]
13. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C
J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621
[TBL] [Abstract][Full Text] [Related]
14. The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus.
Lectez B; Jeandel L; El-Yamani FZ; Arthaud S; Alexandre D; Mardargent A; Jégou S; Mounien L; Bizet P; Magoul R; Anouar Y; Chartrel N
Endocrinology; 2009 May; 150(5):2342-50. PubMed ID: 19164468
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
[TBL] [Abstract][Full Text] [Related]
16. Centrally administered relaxin-3 induces Fos expression in the osmosensitive areas in rat brain and facilitates water intake.
Otsubo H; Onaka T; Suzuki H; Katoh A; Ohbuchi T; Todoroki M; Kobayashi M; Fujihara H; Yokoyama T; Matsumoto T; Ueta Y
Peptides; 2010 Jun; 31(6):1124-30. PubMed ID: 20214940
[TBL] [Abstract][Full Text] [Related]
17. Neuromedin s is a novel anorexigenic hormone.
Ida T; Mori K; Miyazato M; Egi Y; Abe S; Nakahara K; Nishihara M; Kangawa K; Murakami N
Endocrinology; 2005 Oct; 146(10):4217-23. PubMed ID: 15976061
[TBL] [Abstract][Full Text] [Related]
18. Chronic intracerebroventricular administration of anti-neuropeptide Y antibody stimulates starvation-induced feeding via compensatory responses in the hypothalamus.
Ishii T; Muranaka R; Tashiro O; Nishimura M
Brain Res; 2007 May; 1144():91-100. PubMed ID: 17320051
[TBL] [Abstract][Full Text] [Related]
19. Localization of LGR7 (relaxin receptor) mRNA and protein in rat forebrain: correlation with relaxin binding site distribution.
Burazin TC; Johnson KJ; Ma S; Bathgate RA; Tregear GW; Gundlach AL
Ann N Y Acad Sci; 2005 May; 1041():205-10. PubMed ID: 15956709
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
